Trident Texofab Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

13.56

10.07

10.07

10.07

10.07

Share application money

4.11

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

29.57

6.19

5.11

2.89

1.91

Loan funds

Secured loans

26.50

36.96

34.65

35.99

29.15

Unsecured loans

-

-

-

-

-

Total

73.74

53.22

49.83

48.95

41.12

Uses of funds

Fixed assets

Gross block

28.33

28.46

28.56

25.43

16.75

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

8.24

6.73

5.23

3.72

2.54

Net block

20.09

21.73

23.33

21.71

14.21

Capital work-in-progress

-

-

-

3.62

8.89

Investments

1.89

3.74

3.64

2.06

2.48

Net current assets

Current assets, loans & advances

78.59

56.42

50.34

43.60

42.18

Less : current liabilities & provisions

26.84

28.68

27.48

22.04

26.65

Total net current assets

51.75

27.75

22.86

21.55

15.53

Miscellaneous expenses not written

-

-

-

-

-

Total

73.74

53.22

49.83

48.95

41.12

Notes:

Book value of unquoted investments

1.89

3.74

3.64

2.06

2.48

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.05

1.44

1.44

1.44

1.44

Number of equity sharesoutstanding (Lacs)

135.59

100.70

100.70

100.70

100.70